|
Bevacizumab Biosimilar Clinical Trials
3 actively recruiting trials across 1 location
No change since May 2026
Also known as: MVASI
Pipeline
Phase 2: 1Phase 3: 1Phase 1/2: 1
Top Sponsors
- Merck Sharp & Dohme LLC1
- Fudan University1
- Akeso1
Indications
- Cancer3
- Liver Disease2
- Liver Cancer2
- Rectal Adenocarcinoma1
- Colon Adenocarcinoma1
Other2 trials
Los Angeles, California1 trial
A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)
Los Angeles Hematology Oncology Medical Group ( Site 0084)
Phase 3
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.